Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy.

Hebron ML, Lonskaya I, Olopade P, Selby ST, Pagan F, Moussa CE.

J Clin Cell Immunol. 2014 Sep 30;5:259.

2.

A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.

Jacobs ES, Persad D, Ran L, Danesh A, Heitman JW, Deng X, Cameron MJ, Kelvin DJ, Norris PJ.

Retrovirology. 2014 Jul 5;11:57. doi: 10.1186/1742-4690-11-57.

3.

Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

Rot A, McKimmie C, Burt CL, Pallas KJ, Jamieson T, Pruenster M, Horuk R, Nibbs RJ, Graham GJ.

J Immunol. 2013 Jun 15;190(12):6450-6. doi: 10.4049/jimmunol.1201429. Epub 2013 May 13.

4.

Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis.

Settimio R, Clara DF, Franca F, Francesca S, Michele D.

Mediators Inflamm. 2012;2012:318621. doi: 10.1155/2012/318621. Epub 2012 Dec 10.

5.

Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.

Zhang J, Chen H, Liu L, Sun J, Shi MA, Sukhova GK, Shi GP.

Cardiovasc Res. 2012 Dec 1;96(3):543-51. doi: 10.1093/cvr/cvs262. Epub 2012 Aug 7.

6.

Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.

Uyttenhove C, Marillier RG, Tacchini-Cottier F, Charmoy M, Caspi RR, Damsker JM, Goriely S, Su D, Van Damme J, Struyf S, Opdenakker G, Van Snick J.

J Leukoc Biol. 2011 Jun;89(6):1001-7. doi: 10.1189/jlb.1210699. Epub 2011 Mar 8.

7.

Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.

Colobran R, Pedrosa E, Carretero-Iglesia L, Juan M.

Clin Exp Immunol. 2010 Oct;162(1):41-52. doi: 10.1111/j.1365-2249.2010.04224.x. Epub 2010 Aug 19. Review.

8.

Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.

Geonnotti AR, Bilska M, Yuan X, Ochsenbauer C, Edmonds TG, Kappes JC, Liao HX, Haynes BF, Montefiori DC.

AIDS Res Hum Retroviruses. 2010 Mar;26(3):279-91. doi: 10.1089/aid.2009.0186.

9.

Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Vora KA, Porter G, Peng R, Cui Y, Pryor K, Eiermann G, Zaller DM.

BMC Immunol. 2009 Apr 9;10:19. doi: 10.1186/1471-2172-10-19.

10.

Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children.

Shostakovich-Koretskaya L, Catano G, Chykarenko ZA, He W, Gornalusse G, Mummidi S, Sanchez R, Dolan MJ, Ahuja SS, Clark RA, Kulkarni H, Ahuja SK.

AIDS. 2009 Mar 27;23(6):679-88. doi: 10.1097/QAD.0b013e3283270b3f.

11.

Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.

Kulkarni H, Marconi VC, Agan BK, McArthur C, Crawford G, Clark RA, Dolan MJ, Ahuja SK.

PLoS One. 2008;3(11):e3671. doi: 10.1371/journal.pone.0003671. Epub 2008 Nov 7.

12.

Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission.

Meddows-Taylor S, Donninger SL, Paximadis M, Schramm DB, Anthony FS, Gray GE, Kuhn L, Tiemessen CT.

J Gen Virol. 2006 Jul;87(Pt 7):2055-65.

13.

Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Dong HF, Wigmore K, Carrington MN, Dean M, Turpin JA, Howard OM.

Genes Immun. 2005 Oct;6(7):609-19.

Items per page

Supplemental Content

Write to the Help Desk